257 related articles for article (PubMed ID: 1502889)
1. Oncogenesis in ovarian cancer.
Børresen AL
Acta Obstet Gynecol Scand Suppl; 1992; 155():25-30. PubMed ID: 1502889
[TBL] [Abstract][Full Text] [Related]
2. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.
Tripathy D; Benz CC
Cancer Treat Res; 1992; 63():15-60. PubMed ID: 1363356
[TBL] [Abstract][Full Text] [Related]
3. Linkage studies with 17q and 18q markers in a breast/ovarian cancer family.
Milner BJ; Allan LA; Kelly KF; Cruickshank D; Hall M; Johnston A; Kitchener H; Parkin D; Haites N
Am J Hum Genet; 1993 Apr; 52(4):761-6. PubMed ID: 8096360
[TBL] [Abstract][Full Text] [Related]
4. [Genetic alterations in the genesis and development of ovarian cancer].
Okamoto A; Yokoyama S; Terashima Y
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
[TBL] [Abstract][Full Text] [Related]
5. Allelic deletion mapping of putative tumor suppressor genes on 17q in sporadic ovarian cancer.
Chen KC; Hsieh TT; Schwartz PE; Yang-Feng TL
J Obstet Gynaecol (Tokyo 1995); 1995 Dec; 21(6):619-24. PubMed ID: 8640474
[TBL] [Abstract][Full Text] [Related]
6. Suppressor genes in breast cancer: an overview.
Steeg PS
Cancer Treat Res; 1992; 61():45-57. PubMed ID: 1360244
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic changes in human epithelial ovarian malignancies.
Gallion HH; Powell DE; Morrow JK; Pieretti M; Case E; Turker MS; DePriest PD; Hunter JE; van Nagell JR
Gynecol Oncol; 1992 Nov; 47(2):137-42. PubMed ID: 1468689
[TBL] [Abstract][Full Text] [Related]
8. [Molecular analysis of breast cancers: recent developments].
Bièche I; Lidereau R
Bull Cancer; 1992; 79(12):1115-33. PubMed ID: 1304832
[TBL] [Abstract][Full Text] [Related]
9. Genetic studies and molecular markers of bladder cancer.
Cordon-Cardo C; Sheinfeld J; Dalbagni G
Semin Surg Oncol; 1997; 13(5):319-27. PubMed ID: 9259087
[TBL] [Abstract][Full Text] [Related]
10. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
[TBL] [Abstract][Full Text] [Related]
11. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
Aunoble B; Sanches R; Didier E; Bignon YJ
Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
13. Mutations and amplification of oncogenes in endometrial cancer.
Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
[TBL] [Abstract][Full Text] [Related]
14. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
15. [Alterations of c-Myc and c-erbB-2 genes in ovarian tumours].
Pastor T; Popović B; Gvozdenović A; Boro A; Petrović B; Novaković I; Puzović D; Luković L; Milasin J
Srp Arh Celok Lek; 2009; 137(1-2):47-51. PubMed ID: 19370966
[TBL] [Abstract][Full Text] [Related]
16. Recessive oncogenes.
Bookstein R; Allred DC
Cancer; 1993 Feb; 71(3 Suppl):1179-86. PubMed ID: 8428341
[TBL] [Abstract][Full Text] [Related]
17. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
Bergh JC
Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
[TBL] [Abstract][Full Text] [Related]
18. [Genes, heredity and colorectal cancer].
Velu T; Ravelingien N; Parma J; Pector JC
Rev Prat; 1994 Dec; 44(20):2694-9. PubMed ID: 7878358
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in the ovary.
Berchuck A
J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
[TBL] [Abstract][Full Text] [Related]
20. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
Sakamoto T; Nomura N; Mori H; Wake N
Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]